Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Voronova, Ol"'
Autor:
Rybalkina OY; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia. olgatomsk87@gmail.com., Neupokoeva OV; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Voronova OL; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Razina TG; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Kalinkina GI; Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia., Isaikina NV; Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia., Kiseleva EA; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Churin AA; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Zueva EP; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Zhdanov VV; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
Publikováno v:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2023 May; Vol. 175 (1), pp. 49-53. Date of Electronic Publication: 2023 Jun 20.
Autor:
V. E. Gol’dberg, O. V. Pershina, E. P. Feodorova, E. G. Skurikhin, O. V. Kolotova, Karpova Gv, A. A. Churin, Voronova Ol
Publikováno v:
Bulletin of Experimental Biology and Medicine. 145:213-217
Intraperitoneal injection of paclitaxel (Mitotax) in a single dose of 40 mg/kg was followed by an increase in the number of mitotic granulocytic and erythroid cells, hypoplasia, and pancytopenia of the bone marrow in CBA/CaLac mice. The test preparat
Autor:
Neupokoeva OV; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia. repaov@mail.ru., Fedorova EP; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Stavrova LA; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Voronova OL; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Sandrikina LA; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Filonova MV; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Churin AA; E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
Publikováno v:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2020 May; Vol. 169 (1), pp. 43-47. Date of Electronic Publication: 2020 Jun 02.
Autor:
Voronova Ol
Publikováno v:
Bulletin of experimental biology and medicine. 148(3)
Experiments on CBA/CaLac mice showed that single and course administration of proproten-100 did not increase the percent of abnormal metaphases in red bone marrow cells and produced no genotoxic effects in Drosophila melanogaster wing cells in the te
Publikováno v:
Bulletin of Experimental Biology and Medicine. 132
Carboplatin injected intravenously in a maximum permissible dose to Wistar rats inhibited erythro- and granulocytopoiesis in the bone marrow, caused hyporegenerative anemia, leukopenia, and thrombocytopenia in the peripheral blood, led to hypoplasia
Autor:
A. V. Martyushev, A. M. Dygai, O. P. Rogozina, Gol'dberg Ed, Oleg I. Epstein, Voronova Ol, Svetlana Alexandrovna Sergeeva
Publikováno v:
Bulletin of Experimental Biology and Medicine. :65-66
Single and course administration of ultralow doses of antibodies γ-interferon did not increase the incidence of cytogenetic abnormalities in bone marrow cells from BALB/c mice and produced no genotoxic effect on Drosophila melanogaster wing cells in
Autor:
Gol'dberg Ed, Voronova Ol, Yu. M. Dugina, A. V. Martyushev, A. M. Dygai, Oleg I. Epstein, O. P. Rogozina
Publikováno v:
Bulletin of Experimental Biology and Medicine. :75-76
Single and repeated administration of ultralow doses of antibodies to erythropoietin did not increase the count of aberrant metaphases in bone marrow cells of BALB/c mice and were not genotoxic for Drosophila melanogaster wing cells in the test of so
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 2015; Vol. 78 (11), pp. 26-9.
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 2013; Vol. 76 (12), pp. 24-7.